Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ardent Health, Inc. due to alleged violations of federal securities laws related to misleading statements about the company's accounts receivable and professional malpractice liability insurance [1]. Summary by Relevant Sections Legal Action - A federal securities class action has been filed against Ardent Health, with a deadline of March 9, 2026, for investors to seek the role of lead plaintiff [1]. - The complaint alleges that Ardent and its executives made false or misleading statements and failed to disclose critical information regarding the company's financials [1]. Financial Impact - On November 12, 2025, Ardent reported a $43 million reduction in revenue and a $54 million increase in professional liability reserves due to accounting changes [1]. - Following this announcement, Ardent's stock price dropped by $4.75 per share, or 33.81%, closing at $9.30 per share on November 13, 2025 [1]. Investor Information - Investors who purchased securities between July 18, 2024, and November 12, 2025, are encouraged to contact Faruqi & Faruqi for discussions regarding their legal rights [1]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [1].
ARDT DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on March 9, 2026